| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2620 | 2020 |
| Initiation strategies for renal-replacement therapy in the intensive care unit S Gaudry, D Hajage, F Schortgen, L Martin-Lefevre, B Pons, E Boulet, ... New England Journal of Medicine 375 (2), 122-133, 2016 | 1157 | 2016 |
| IgA dominates the early neutralizing antibody response to SARS-CoV-2 D Sterlin, A Mathian, M Miyara, A Mohr, F Anna, L Claër, P Quentric, ... Science translational medicine 13 (577), eabd2223, 2021 | 1025 | 2021 |
| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 920 | 2021 |
| Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en reanimation onco … E Azoulay, D Mokart, F Pène, J Lambert, A Kouatchet, J Mayaux, ... Journal of Clinical Oncology 31 (22), 2810-2818, 2013 | 650 | 2013 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 501 | 2021 |
| Coexistence and impact of limb muscle and diaphragm weakness at time of liberation from mechanical ventilation in medical intensive care unit patients M Dres, BP Dubé, J Mayaux, J Delemazure, D Reuter, L Brochard, ... American journal of respiratory and critical care medicine 195 (1), 57-66, 2017 | 458 | 2017 |
| Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study M Schmidt, D Hajage, G Lebreton, A Monsel, G Voiriot, D Levy, E Baron, ... The Lancet Respiratory Medicine 8 (11), 1121-1131, 2020 | 417 | 2020 |
| Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. D Annane, A Cariou, V Maxime, E Azoulay, G D'honneur, JF Timsit, ... Jama 303 (4), 341-348, 2010 | 395 | 2010 |
| Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled … F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ... The Lancet infectious diseases 22 (2), 209-221, 2022 | 375 | 2022 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 368 | 2021 |
| Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial V Lemiale, D Mokart, M Resche-Rigon, F Pène, J Mayaux, E Faucher, ... Jama 314 (16), 1711-1719, 2015 | 341 | 2015 |
| Acute respiratory distress syndrome in patients with malignancies E Azoulay, V Lemiale, D Mokart, F Pène, A Kouatchet, P Perez, F Vincent, ... Intensive care medicine 40, 1106-1114, 2014 | 289 | 2014 |
| Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial E Azoulay, V Lemiale, D Mokart, S Nseir, L Argaud, F Pène, L Kontar, ... Jama 320 (20), 2099-2107, 2018 | 286 | 2018 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 275 | 2022 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 266 | 2021 |
| Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study JP Gangneux, E Dannaoui, A Fekkar, CE Luyt, F Botterel, N De Prost, ... The Lancet Respiratory Medicine 10 (2), 180-190, 2022 | 239 | 2022 |
| COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings C Delorme, O Paccoud, A Kas, A Hesters, S Bombois, P Shambrook, ... European journal of neurology 27 (12), 2651-2657, 2020 | 190 | 2020 |
| Ultrasound evaluation of diaphragm function in mechanically ventilated patients: comparison to phrenic stimulation and prognostic implications BP Dubé, M Dres, J Mayaux, S Demiri, T Similowski, A Demoule Thorax 72 (9), 811-818, 2017 | 190 | 2017 |
| Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU A Fekkar, A Lampros, J Mayaux, C Poignon, S Demeret, JM Constantin, ... American journal of respiratory and critical care medicine 203 (3), 307-317, 2021 | 180 | 2021 |
